Public, NASDAQ:BPAX
NASDAQ Global Market
Earnings Update: Biosante Pharmaceuticals Releases its Quarterly Earnings on August 06, 2010 (BPAX)
Date: Sun, 25 Jul 2010 22:46:55 GMT
Tags:
Earnings Update: Biosante Pharmaceuticals Releases its Quarterly Earnings on August 06, 2010 (BPAX)
Comtex Smartrend - Jul 25, 2010
Comtex Smartrend - Jul 25, 2010
By Chip Brian Analysts, on average, expect Biosante Pharmaceuticals (NASDAQ:BPAX) to report a loss of $0.12 on sales of $200 thousand on August 06, 2010. For the full year, analysts expect the ...
What Investors Think About BioSante Pharmaceuticals
Date: Fri, 23 Jul 2010 05:23:36 GMT
Tags:
What Investors Think About BioSante Pharmaceuticals
The Money Times - Jul 23, 2010
The Money Times - Jul 23, 2010
by Motley Fool - July 23, 2010 - 0 comments Together, we are all trying to build our fortune by finding well-run companies at bargain-basement prices. But it takes work -- scouring company ...
Biosante Pharmaceuticals Falls 4.88% on Heavy Volume: Watch For Rebound (BPAX)
Date: Thu, 22 Jul 2010 08:49:44 GMT
Tags:
Biosante Pharmaceuticals Falls 4.88% on Heavy Volume: Watch For Rebound (BPAX)
Comtex Smartrend - Jul 22, 2010
Comtex Smartrend - Jul 22, 2010
By Chip Brian Biosante Pharmaceuticals (NASDAQ:BPAX) traded in a range yesterday that spanned from a low of $1.55 to a high of $1.65. Yesterday, the shares fell 4.88%, which took the trading range ...
BioSante Pharmaceuticals Inc. (BPAX) Corporate Event Announcement Notice
Date: Thu, 22 Jul 2010 00:51:47 GMT
Tags:
BioSante Pharmaceuticals Inc. (BPAX) Corporate Event Announcement Notice
Trading Markets - Jul 22, 2010
Trading Markets - Jul 22, 2010
For full details on Biosante Pharmaceuticals (BPAX) BPAX. Biosante Pharmaceuticals (BPAX) has Short Term PowerRatings at TradingMarkets. Details on Biosante Pharmaceuticals (BPAX) Short Term ...
BioSante Pharmaceuticals Announces Initiation of LibiGel® Study to Evaluate its Effect on Cognitive Function in Women
Date: Tue, 13 Jul 2010 11:56:56 GMT
Tags:
BioSante Pharmaceuticals Announces Initiation of LibiGel® Study to Evaluate its Effect on Cognitive Function in Women
Business Wire - Jul 13, 2010
BioSante Pharmaceuticals Announces Initiation Of LibiGel® Study To Evaluate Its Effect On Cognitive Function In Women - TheStreet.com
Forbes - StreetInsider.com - News-Medical.net
Business Wire - Jul 13, 2010
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the initiation of a LibiGel ® (testosterone gel) clinical trial to evaluate its effect on ...
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) Study to Evaluate its Effect on Cognitive Function in Women - MarketWatchBioSante Pharmaceuticals Announces Initiation Of LibiGel® Study To Evaluate Its Effect On Cognitive Function In Women - TheStreet.com
Forbes - StreetInsider.com - News-Medical.net
Novartis Thwarted in Oral MS Drug Race (at Minyanville)
Date: Wed, 28 Jul 2010 17:20:00 GMT
Tags:
Merck KGaA gets priority review for its oral MS drug, encroaching on what was once Gilenia's exclusive territory.
Big Pharma Makes Money, But Fails to Impress (at Minyanville)
Date: Fri, 23 Jul 2010 17:10:00 GMT
Tags:
While most companies that have reported earnings have met or exceeded analysts' expectations, the macro-economic picture for the sector looks bleak.
What Investors Think About BioSante Pharmaceuticals (at Motley Fool)
Date: Thu, 22 Jul 2010 17:46:42 GMT
Tags:
Volume Hunter: Biotech (Indie Research)
Date: Fri, 16 Jul 2010 15:08:00 GMT
Tags:
The biotech sector is among the most volatile on Wall Street, and as such it is a favorite among active traders.
Six Trades on FDA, Clinical Trial Binary Events (at Seeking Alpha)
Date: Tue, 13 Jul 2010 20:49:31 GMT
Tags: